Discontinued drugs in 2012 - 2013: hepatitis C virus infection.

Discontinued drugs in 2012 - 2013: hepatitis C virus infection.

Item
http://www.wikidata.org/entity/Q39100351
Limiting the access to direct-acting antivirals against HCV: an ethical dilemma.Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development.Biophysical Mode-of-Action and Selectivity Analysis of Allosteric Inhibitors of Hepatitis C Virus (HCV) Polymerase.Beclabuvir for the treatment of hepatitis C.Asunaprevir for hepatitis C: a safety evaluation.Computational Membrane Biophysics: From Ion Channels Interactions with Drugs to Cellular Function.Small-molecule inhibitors of hepatitis C virus (HCV) non-structural protein 5A (NS5A): a patent review (2010-2015).The ProTides Boom.Advanced asymmetric synthesis of (1R,2S)-1-amino-2-vinylcyclopropanecarboxylic acid by alkylation/cyclization of newly designed axially chiral Ni(II) complex of glycine Schiff base.NS5B polymerase inhibitors in phase II clinical trials for HCV infection.
P2860

Discontinued drugs in 2012 - 2013: hepatitis C virus infection.

Item
http://www.wikidata.org/entity/Q39100351
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Discontinued drugs in 2012 - 2013: hepatitis C virus infection.
@en
Discontinued drugs in 2012 - 2013: hepatitis C virus infection.
@nl
type
label
Discontinued drugs in 2012 - 2013: hepatitis C virus infection.
@en
Discontinued drugs in 2012 - 2013: hepatitis C virus infection.
@nl
prefLabel
Discontinued drugs in 2012 - 2013: hepatitis C virus infection.
@en
Discontinued drugs in 2012 - 2013: hepatitis C virus infection.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Discontinued drugs in 2012 - 2013: hepatitis C virus infection.
@en
P2093
P2860
P304
P31
P356
10.1517/13543784.2015.982274
P407
P433
P478
P50
P577
P698